Svetlana Lucas serves as Executive at aTYR PHARMA INC, where they oversee executive responsibilities. Since joining the company, Svetlana Lucas has executed 2 insider transactions totaling $48.6K, demonstrating a bullish approach to their equity position. Their most recent transaction on Sep 22, 2025 involved purchasing 20,000 shares valued at $48.6K.
Svetlana Lucas currently holds 20,000 shares of aTYR PHARMA INC (LIFE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Svetlana Lucas has been a net buyer of LIFE stock. They have purchased $48.6K and sold $0 worth of shares.
Svetlana Lucas's most recent insider trade was on Sep 22, 2025, when they purchased 20,000 shares at $2.43 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |